Gene · 129607
Papers1,751
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,751
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Stochastic assembly of biomacromolecular complexes: impact and implications on charge interpretation in native mass spectrometry. | Chem Sci | 2023 | 37712025 | PubTator, text mining | PubMed |
| A novel synthesized prodrug of gemcitabine based on oxygen-free radical sensitivity inhibited the growth of lung cancer cells. | J Biomed Res | 2023 | 37705111 | PubTator, text mining | PubMed |
| Betacoronaviruses SARS-CoV-2 and HCoV-OC43 infections in IGROV-1 cell line require aryl hydrocarbon receptor. | Emerg Microbes Infect | 2023 | 37672505 | PubTator, text mining | PubMed |
| Targeted splicing therapy: new strategies for colorectal cancer. | Front Oncol | 2023 | 37664052 | PubTator, text mining | PubMed |
| Decoding brain calcifications: A single-center descriptive case series and examination of pathophysiological mechanisms. | SAGE Open Med Case Rep | 2023 | 37663154 | PubTator, text mining | PubMed |
| Mammalian Nudt15 hydrolytic and binding activity on methylated guanosine mononucleotides. | Eur Biophys J | 2023 | 37644211 | PubTator, text mining | PubMed |
| Spatial transcriptome atlas reveals pulmonary microstructure-specific COVID-19 gene signatures in cynomolgus macaques. | Commun Biol | 2023 | 37640792 | PubTator, text mining | PubMed |
| Type I Interferon Pathway-Related Hub Genes as a Potential Therapeutic Target for SARS-CoV-2 Omicron Variant-Induced Symptoms. | Microorganisms | 2023 | 37630661 | PubTator, text mining | PubMed |
| DNA Methylation Signatures of Multiple Sclerosis Occur Independently of Known Genetic Risk and Are Primarily Attributed to B Cells and Monocytes. | Int J Mol Sci | 2023 | 37628757 | PubTator, text mining | PubMed |
| Recent Advances in Molecular Mechanisms of Nucleoside Antivirals. | Curr Issues Mol Biol | 2023 | 37623252 | PubTator, text mining | PubMed |
| A Comprehensive Insight and Mechanistic Understanding of the Lipidomic Alterations Associated With DCM. | JACC Asia | 2023 | 37614533 | PubTator, text mining | PubMed |
| Dectin-1 stimulation promotes a distinct inflammatory signature in the setting of HIV-infection and aging. | Aging (Albany NY) | 2023 | 37606991 | PubTator, text mining | PubMed |
| HELZ2: a new, interferon-regulated, human 3'-5' exoribonuclease of the RNB family is expressed from a non-canonical initiation codon. | Nucleic Acids Res | 2023 | 37602378 | PubTator, text mining | PubMed |
| Chemoenzymatic Synthesis of 3'-Deoxy-3',4'-didehydro-cytidine triphosphate (ddhCTP). | ACS Bio Med Chem Au | 2023 | 37599790 | PubTator, text mining | PubMed |
Corrigendum to "Endothelial Gata6 deletion reduces monocyte recruitment and proinflammatory macrophage formation and attenuates atherosclerosis through Cmpk2-Nlrp3 pathways" [Redox Biol. 64 (2023) 102775]. | Redox Biol | 2023 | 37596238 | PubTator, text mining | PubMed |
| The regulation of lncRNAs and miRNAs in SARS-CoV-2 infection. | Front Cell Dev Biol | 2023 | 37576600 | PubTator, text mining | PubMed |
| NME6: ribonucleotide salvage sustains mitochondrial transcription. | EMBO J | 2023 | 37548337 | PubTator, text mining | PubMed |
| Application of G-quadruplex targets in gastrointestinal cancers: Advancements, challenges and prospects. | World J Gastrointest Oncol | 2023 | 37546556 | PubTator, text mining | PubMed |
| Reframing the link between metabolism and NLRP3 inflammasome: therapeutic opportunities. | Front Immunol | 2023 | 37545507 | PubTator, text mining | PubMed |
| Long noncoding RNA 1392 regulates MDA5 by interaction with ELAVL1 to inhibit coxsackievirus B5 infection. | Virol Sin | 2023 | 37543144 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/129607/papers?page=8